|
|||||
|
|
Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy |
|
| Authors: | Chang Jennie T Staffa Judy A Parks Mary Green Lanh |
| Affiliation: | Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA. changJ@cder.fda.gov |
| Abstract: | |
| Keywords: | rhabdomyolysis statins fibrates HMG‐CoA reductase inhibitors adverse reactions renal failure |
| 本文献已被 PubMed 等数据库收录！ | |